Firefly Neuroscience, Inc. (AIFF) - Total Assets
Based on the latest financial reports, Firefly Neuroscience, Inc. (AIFF) holds total assets worth $12.41 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Firefly Neuroscience, Inc. - Total Assets Trend (2020–2024)
This chart illustrates how Firefly Neuroscience, Inc.'s total assets have evolved over time, based on quarterly financial data. Also see Firefly Neuroscience, Inc. market cap and net worth for the company's overall valuation and market capitalisation.
Firefly Neuroscience, Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
Firefly Neuroscience, Inc.'s total assets of $12.41 Million consist of 57.1% current assets and 42.9% non-current assets. Review debt load of Firefly Neuroscience, Inc. to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 39.3% |
| Accounts Receivable | $121.00K | 2.6% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $180.00K | 3.9% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how Firefly Neuroscience, Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest Firefly Neuroscience, Inc. stock price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Firefly Neuroscience, Inc.'s current assets represent 57.1% of total assets in 2024, a decrease from 88.9% in 2020.
- Cash Position: Cash and equivalents constituted 39.3% of total assets in 2024, down from 49.2% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2020.
- Asset Diversification: The largest asset category is intangible assets at 3.9% of total assets.
Firefly Neuroscience, Inc. Competitors by Total Assets
Key competitors of Firefly Neuroscience, Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Kingsoft Office Software In
SHG:688111
|
China | CN¥20.22 Billion |
|
Xero Ltd
AU:XRO
|
Australia | AU$6.10 Billion |
|
Webull Corp
NASDAQ:BULL
|
USA | $3.88 Billion |
|
Douzone Bizon Co Ltd
KO:012510
|
Korea | ₩1.15 Trillion |
|
Shanghai Suochen Information Technology Co. Ltd. A
SHG:688507
|
China | CN¥3.41 Billion |
|
Beijing Topnew Info And Tech Co Ltd
SHE:300895
|
China | CN¥948.32 Million |
|
TRUSTPILOT GROUP LS -01
F:6VZ
|
Germany | €127.51 Million |
|
Beijing Global Safety Technology Co Ltd
SHE:300523
|
China | CN¥3.97 Billion |
Firefly Neuroscience, Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.00 | 1.05 | 0.04 |
| Quick Ratio | 1.97 | 1.05 | 0.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.71 Million | $130.00K | $-2.16 Million |
Firefly Neuroscience, Inc. - Advanced Valuation Insights
This section examines the relationship between Firefly Neuroscience, Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.56 |
| Latest Market Cap to Assets Ratio | 2.87 |
| Asset Growth Rate (YoY) | 74.2% |
| Total Assets | $4.60 Million |
| Market Capitalization | $13.22 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Firefly Neuroscience, Inc.'s assets at a significant premium (2.87x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Firefly Neuroscience, Inc.'s assets grew by 74.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Firefly Neuroscience, Inc. (2020–2024)
The table below shows the annual total assets of Firefly Neuroscience, Inc. from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $4.60 Million | +74.21% |
| 2023-12-31 | $2.64 Million | +1856.30% |
| 2022-12-31 | $135.00K | -85.83% |
| 2021-12-31 | $953.00K | -74.75% |
| 2020-12-31 | $3.77 Million | -- |
About Firefly Neuroscience, Inc.
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depres… Read more